AXON
Axon Enterprise, Inc. NASDAQ Listed Jun 19, 2001$426.79
Mkt Cap $34.4B
52w Low $339.01
16.1% of range
52w High $885.92
50d MA $451.05
200d MA $595.51
P/E (TTM)
251.4x
EV/EBITDA
236.1x
P/B
10.0x
Debt/Equity
0.6x
ROE
3.8%
P/FCF
608.1x
RSI (14)
—
ATR (14)
—
Beta
1.60
50d MA
$451.05
200d MA
$595.51
Avg Volume
1.1M
Axon Enterprise, Inc. develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence. Its products include TASER 7, TASER X26P, TASER X2, TASER Consumer devices, and related cartridges; on-officer body cameras, Axon Fleet in-car systems, and other devices; Axon Evidence digital evidence management software; Axon Signal enabled devices, as well as hardware extended warranties; and Axon docks, cartridges, and batteries. It sells its products through its direct sales force, distribution partners, online store, and third-party resellers. Axon Enterprise, Inc. has a strategic partnership with Fusus, Inc. to expand the capabilities of Axon Respond and the Fusus Real Time Crime Center in the Cloud solution to provide agencies real-time operations situational awareness, including streamlined investigative workflows. The company was formerly known as TASER International, Inc. and changed its name to Axon Enterprise, Inc. in April 2017. Axon Enterprise, Inc. was incorporated in 1993 and is headquartered in Scottsdale, Arizona.
17800 North 85th Street · Scottsdale, AZ 85255 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | AMC | 1.60 | 1.61 | +0.6% | 385.86 | +5.8% | +10.6% | — | — | — | — | — |
| Feb 24, 2026 | AMC | 1.60 | 2.15 | +34.4% | 442.51 | +12.6% | +17.6% | +5.8% | -1.4% | +5.5% | +1.2% | — |
| Nov 4, 2025 | AMC | 1.52 | 1.17 | -23.0% | 706.13 | -20.2% | -9.4% | -8.2% | +2.6% | -3.0% | -2.1% | — |
| Aug 4, 2025 | AMC | 1.45 | 2.12 | +46.2% | 744.88 | +9.8% | +16.4% | -0.4% | +0.8% | -3.3% | -2.8% | — |
| May 7, 2025 | AMC | 1.27 | 1.41 | +11.0% | 601.82 | +7.4% | +14.1% | -0.3% | +1.2% | +4.6% | +0.5% | — |
| Feb 25, 2025 | AMC | 1.37 | 2.08 | +51.8% | 496.65 | +17.8% | +15.3% | -8.2% | +0.6% | -0.5% | +0.5% | — |
| Nov 7, 2024 | AMC | 1.20 | 1.45 | +20.8% | 468.75 | +15.2% | +28.7% | +2.1% | -3.4% | +1.0% | +0.5% | — |
| Aug 6, 2024 | AMC | 1.02 | 1.20 | +17.6% | 295.00 | +11.9% | +18.4% | +5.5% | -0.9% | +0.8% | +0.3% | — |
| May 6, 2024 | AMC | 0.94 | 1.15 | +21.7% | 327.64 | -4.5% | -4.6% | -0.3% | -0.9% | -1.8% | -1.1% | — |
| Feb 27, 2024 | AMC | 0.86 | 1.12 | +30.2% | 271.82 | +3.3% | +13.8% | -0.6% | +2.2% | +1.8% | -1.5% | — |
| Nov 7, 2023 | AMC | 0.76 | 1.02 | +34.2% | 216.37 | +3.8% | +6.1% | -6.0% | +1.0% | +0.3% | +1.3% | — |
| Aug 8, 2023 | AMC | 0.62 | 1.11 | +79.0% | 175.73 | +12.7% | +14.1% | +1.8% | +3.5% | -2.2% | -1.7% | — |
| May 9, 2023 | AMC | 0.46 | 0.88 | +91.3% | 226.88 | -1.8% | -15.1% | +6.2% | -1.5% | +1.0% | -1.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 16 | JP Morgan | Maintains | Overweight → Overweight | — | $402.18 | $413.01 | +2.7% | -2.3% | +2.5% | +0.2% | +0.3% | -0.4% |
| Apr 13 | Citizens | Maintains | Market Outperform → Market Outperform | — | $345.94 | $345.89 | -0.0% | +4.0% | +5.9% | +5.6% | -2.3% | +2.5% |
| Apr 8 | TD Cowen | Maintains | Buy → Buy | — | $372.87 | $400.95 | +7.5% | +5.0% | -10.3% | -1.5% | +4.0% | +5.9% |
| Apr 8 | Goldman Sachs | Maintains | Buy → Buy | — | $372.87 | $400.95 | +7.5% | +5.0% | -10.3% | -1.5% | +4.0% | +5.9% |
| Feb 25 | UBS | Maintains | Neutral → Neutral | — | $442.51 | $498.43 | +12.6% | +17.6% | +5.8% | -1.4% | +5.5% | +1.2% |
| Feb 25 | Morgan Stanley | Maintains | Overweight → Overweight | — | $442.51 | $498.43 | +12.6% | +17.6% | +5.8% | -1.4% | +5.5% | +1.2% |
| Feb 25 | Piper Sandler | Maintains | Overweight → Overweight | — | $442.51 | $498.43 | +12.6% | +17.6% | +5.8% | -1.4% | +5.5% | +1.2% |
| Feb 25 | Barclays | Maintains | Overweight → Overweight | — | $442.51 | $498.43 | +12.6% | +17.6% | +5.8% | -1.4% | +5.5% | +1.2% |
| Feb 25 | RBC Capital | Maintains | Outperform → Outperform | — | $442.51 | $498.43 | +12.6% | +17.6% | +5.8% | -1.4% | +5.5% | +1.2% |
| Feb 20 | Needham | Maintains | Buy → Buy | — | $441.12 | $435.17 | -1.3% | -1.6% | -2.4% | +4.5% | +17.6% | +5.8% |
| Dec 17 | Morgan Stanley | Maintains | Overweight → Overweight | — | $555.06 | $546.34 | -1.6% | -0.9% | +2.4% | +5.5% | +1.0% | -1.5% |
| Nov 6 | Barclays | Maintains | Overweight → Overweight | — | $639.53 | $628.60 | -1.7% | -8.2% | +2.6% | -3.0% | -2.1% | -0.5% |
| Nov 5 | UBS | Maintains | Neutral → Neutral | — | $706.13 | $563.84 | -20.2% | -9.4% | -8.2% | +2.6% | -3.0% | -2.1% |
| Nov 5 | Piper Sandler | Maintains | Overweight → Overweight | — | $706.13 | $563.84 | -20.2% | -9.4% | -8.2% | +2.6% | -3.0% | -2.1% |
| Nov 5 | Goldman Sachs | Maintains | Buy → Buy | — | $706.13 | $563.84 | -20.2% | -9.4% | -8.2% | +2.6% | -3.0% | -2.1% |
| Sep 29 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $708.84 | $716.34 | +1.1% | +1.0% | +0.2% | -0.9% | +1.3% | -0.7% |
| Sep 24 | Needham | Maintains | Buy → Buy | — | $777.58 | $789.29 | +1.5% | -10.2% | +2.0% | -0.5% | +1.0% | +0.2% |
| Aug 6 | BofA Securities | Maintains | Buy → Buy | — | $867.12 | $859.76 | -0.8% | -0.4% | +0.8% | -3.3% | -2.8% | -6.1% |
| Aug 5 | Raymond James | Maintains | Outperform → Outperform | — | $744.88 | $818.00 | +9.8% | +16.4% | -0.4% | +0.8% | -3.3% | -2.8% |
| Aug 5 | UBS | Maintains | Neutral → Neutral | — | $744.88 | $818.00 | +9.8% | +16.4% | -0.4% | +0.8% | -3.3% | -2.8% |
| Aug 5 | Northland Capital Markets | Maintains | Outperform → Outperform | — | $744.88 | $818.00 | +9.8% | +16.4% | -0.4% | +0.8% | -3.3% | -2.8% |
| Aug 5 | Craig-Hallum | Upgrade | Hold → Buy | — | $744.88 | $818.00 | +9.8% | +16.4% | -0.4% | +0.8% | -3.3% | -2.8% |
| Aug 5 | Needham | Maintains | Buy → Buy | — | $744.88 | $818.00 | +9.8% | +16.4% | -0.4% | +0.8% | -3.3% | -2.8% |
| Jul 22 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $751.55 | $749.01 | -0.3% | -4.1% | -2.2% | +0.6% | +3.6% | +0.2% |
| Jul 17 | JP Morgan | Maintains | Overweight → Overweight | — | $742.77 | $744.80 | +0.3% | +0.4% | +1.4% | -0.6% | -4.1% | -2.2% |
| Jun 4 | BofA Securities | Maintains | Buy → Buy | — | $759.07 | $760.00 | +0.1% | +2.8% | +1.1% | +0.4% | -1.0% | -2.7% |
| May 14 | Goldman Sachs | Maintains | Buy → Buy | — | $724.77 | $725.00 | +0.0% | +0.5% | -0.0% | +0.7% | +1.2% | +0.1% |
| May 9 | Barclays | Maintains | Overweight → Overweight | — | $686.83 | $684.01 | -0.4% | -0.3% | +1.2% | +4.6% | +0.5% | -0.0% |
| May 8 | Northland Capital Markets | Maintains | Outperform → Outperform | — | $601.82 | $646.38 | +7.4% | +14.1% | -0.3% | +1.2% | +4.6% | +0.5% |
| May 8 | Needham | Maintains | Buy → Buy | — | $601.82 | $646.38 | +7.4% | +14.1% | -0.3% | +1.2% | +4.6% | +0.5% |
| Apr 23 | Needham | Maintains | Buy → Buy | — | $555.52 | $576.40 | +3.8% | +3.8% | +2.4% | +2.2% | -0.2% | +1.4% |
| Feb 27 | Barclays | Maintains | Overweight → Overweight | — | $572.40 | $575.00 | +0.5% | -8.2% | +0.6% | -0.5% | +0.5% | +1.3% |
| Feb 26 | Needham | Maintains | Buy → Buy | — | $496.65 | $584.95 | +17.8% | +15.3% | -8.2% | +0.6% | -0.5% | +0.5% |
| Feb 26 | Citizens Capital Markets | Maintains | Market Outperform → Market Outperform | — | $496.65 | $584.95 | +17.8% | +15.3% | -8.2% | +0.6% | -0.5% | +0.5% |
| Feb 20 | Craig-Hallum | Downgrade | Buy → Hold | — | $593.42 | $581.00 | -2.1% | -8.7% | -5.3% | -2.6% | -0.6% | +15.3% |
| Feb 4 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $658.11 | $657.14 | -0.1% | +0.7% | +2.7% | -0.5% | +0.3% | -0.2% |
| Jan 27 | Goldman Sachs | Maintains | Buy → Buy | — | $610.32 | $597.79 | -2.1% | -0.9% | +5.4% | +0.4% | +2.1% | -0.2% |
| Dec 6 | Baird | Maintains | Outperform → Outperform | — | $689.78 | $689.73 | -0.0% | -0.3% | -6.6% | -0.8% | +0.8% | -0.9% |
| Dec 3 | Morgan Stanley | Upgrade | Equal Weight → Overweight | — | $636.39 | $652.82 | +2.6% | +5.3% | +2.6% | +0.3% | -0.3% | -6.6% |
| Nov 11 | Northland Capital Markets | Maintains | Outperform → Outperform | — | $603.18 | $611.06 | +1.3% | +2.1% | -3.4% | +1.0% | +0.5% | -0.9% |
| Nov 8 | Needham | Maintains | Buy → Buy | — | $468.75 | $540.00 | +15.2% | +28.7% | +2.1% | -3.4% | +1.0% | +0.5% |
| Nov 8 | Baird | Maintains | Outperform → Outperform | — | $468.75 | $540.00 | +15.2% | +28.7% | +2.1% | -3.4% | +1.0% | +0.5% |
| Nov 4 | Baird | Maintains | Outperform → Outperform | — | $425.84 | $425.84 | +0.0% | +1.3% | +2.2% | +4.2% | +2.0% | +28.7% |
| Oct 31 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $439.00 | $435.96 | -0.7% | -3.5% | +0.6% | +1.3% | +2.2% | +4.2% |
| Aug 8 | Northland Capital Markets | Maintains | Outperform → Outperform | — | $349.24 | $350.90 | +0.5% | +5.5% | -0.9% | +0.8% | +0.3% | +0.4% |
| Aug 7 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $295.00 | $330.00 | +11.9% | +18.4% | +5.5% | -0.9% | +0.8% | +0.3% |
| Aug 7 | Needham | Maintains | Buy → Buy | — | $295.00 | $330.00 | +11.9% | +18.4% | +5.5% | -0.9% | +0.8% | +0.3% |
| Aug 7 | Baird | Maintains | Outperform → Outperform | — | $295.00 | $330.00 | +11.9% | +18.4% | +5.5% | -0.9% | +0.8% | +0.3% |
| Aug 7 | Barclays | Maintains | Overweight → Overweight | — | $295.00 | $330.00 | +11.9% | +18.4% | +5.5% | -0.9% | +0.8% | +0.3% |
| Aug 7 | Craig-Hallum | Maintains | Buy → Buy | — | $295.00 | $330.00 | +11.9% | +18.4% | +5.5% | -0.9% | +0.8% | +0.3% |
No insider trades available.
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Axon Enterprise's executive leadership change could signal strategic direction shifts; investors should monitor whether the new executive strengthens operations or creates uncertainty about company stability and future performance.
Apr 10
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Axon's executive departure signals potential leadership transition risks, though the specific role isn't detailed; investors should monitor replacement announcements to assess continuity of strategy and operational execution.
Mar 11
8-K
Axon Enterprise, Inc. -- 8-K Filing
Axon Enterprise delivered 33% revenue growth with expanding profitability margins and strong Rule of 40 metrics, demonstrating sustained momentum in its law enforcement software ecosystem despite continued investments.
Feb 24
8-K · 8.01
!! High
Axon Enterprise, Inc. -- 8-K 8.01: Material Event / Announcement
Axon Enterprise is redeeming its 0.50% convertible senior notes due 2027, receiving 41,139 shares from option counterparties exercising convertible note hedges, reducing future dilution.
Feb 13
8-K · 8.01
!! High
Axon Enterprise, Inc. -- 8-K 8.01: Material Event / Announcement
Axon Enterprise declared a Market Disruption Event on January 29, 2026, which excludes that date from the observation period for convertible note settlement calculations, potentially affecting conversion value for noteholders.
Feb 4
Data updated apr 24, 2026 8:13pm
· Source: massive.com